0001104659-24-039199.txt : 20240326 0001104659-24-039199.hdr.sgml : 20240326 20240326202354 ACCESSION NUMBER: 0001104659-24-039199 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240322 FILED AS OF DATE: 20240326 DATE AS OF CHANGE: 20240326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rondoni John CENTRAL INDEX KEY: 0001932219 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38468 FILM NUMBER: 24785457 MAIL ADDRESS: STREET 1: C/O INSPIRE MEDICAL SYSTEMS, INC. STREET 2: 9700 63RD AVENUE NORTH, SUITE 200 CITY: MAPLE GROVE STATE: MN ZIP: 55369 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inspire Medical Systems, Inc. CENTRAL INDEX KEY: 0001609550 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 261377674 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5500 WAYZATA BLVD STREET 2: SUITE 1600 CITY: GOLDEN VALLEY STATE: MN ZIP: 55416 BUSINESS PHONE: 763-957-5037 MAIL ADDRESS: STREET 1: 5500 WAYZATA BLVD STREET 2: SUITE 1600 CITY: GOLDEN VALLEY STATE: MN ZIP: 55416 4 1 tm249882-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-03-22 0 0001609550 Inspire Medical Systems, Inc. INSP 0001932219 Rondoni John C/O INSPIRE MEDICAL SYSTEMS, INC. 5500 WAYZATA BLVD., SUITE 1600 GOLDEN VALLEY MN 55416 0 1 0 0 Chief Technology Officer 1 Common Stock 2024-03-22 4 S 0 825 193.70 D 14832 D Common Stock 2024-03-22 4 S 0 3062 194.46 D 11770 D Common Stock 2024-03-22 4 S 0 500 195.22 D 11270 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.19 to $194.00. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.225 to $194.985. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.21 to $195.23. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. All transactions reported herein were made pursuant to a Rule 10b5-1 trading plan dated November 30, 2023. /s/ Bryan Phillips, Attorney-in-Fact for John Rondoni 2024-03-26